Randomized study comparing simultaneous injection with sequential injection of Fulvestrant

Randomized study comparing simultaneous injection with sequential injection of Fulvestrant - Randomized study of injection methods of Fulvestrant

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000009563

Enrollment

Registered

2012-12-17

Start date

2012-12-17

Completion date

Unknown

Last updated

2025-07-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postmenopausal breast cancer

Interventions

1st time:Two shots of Fulvestrant are injected to each buttock sequentially 2nd time:Those are injected to each buttock simultaneously 3rd Time and after:Those are injected to each buttock according

choice 1st time:Two shots of Fulvestrant are injected to each buttock simultanously 2nd time:Those are injected to each buttock sequentially 3rd Time and after:Those are injected to each buttock a

choice

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria:

Exclusion criteria

Exclusion criteria: 1)Patients who are impossible to be enrolled with psychological diseases or disorder 2)Inappropriate patients by investigator' decision

Design outcomes

Primary

Measure	Time frame
1) Visual analog scales for simultaneous and sequential injections of Fulverant 2) Patient choice of injection method of Fulverant for 3rd time and after	—

Secondary

Measure	Time frame
1) Time for injections 2) Questionnaire to patients regarding each injection method 3) Questionnaire to nurses regarding each injection method	—

Countries

Japan

Contacts

Public ContactKazutaka Narui

Yokohama City University Medical Center Breast and thyroid surgery

nr1@gc5.so-net.ne.jp045-261-5656

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Feb 4, 2026